Wangyu Ye

Chinese Academy of Medical Sciences & Peking Union Medical College

Publishes on Pharmacovigilance and Adverse Drug Reactions, Psoriasis: Treatment and Pathogenesis, Attention Deficit Hyperactivity Disorder. 6 papers and 39 citations.

PubIndex Score75Top 25% · early-careerHow it's scored

6Publications

39Total Citations

First publication: 2009First senior author: 2024

Pharmacovigilance and Adverse Drug Reactions Psoriasis: Treatment and Pathogenesis Attention Deficit Hyperactivity Disorder Advancements in Transdermal Drug Delivery Neuroendocrine Tumor Research Advances

Top publicationsby citations

Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database

Wangyu Ye, Zhen Liu, Meng Li et al.|Frontiers in Pharmacology|2024

Cited by 21

Mitochondria-targeted curcumin microneedles for psoriasis therapy via autophagy activation and epidermal hyperplasia suppression

Wentao Wu, Wenhao Wang, Guanlin Wang et al.|International Journal of Pharmaceutics|2025

Cited by 9

Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database

Wangyu Ye, Zhen Liu, Yuan Ding et al.|PLoS ONE|2025

Cited by 6

Real-world drug safety study of somatostatin analogs based on the food and drug administration adverse event reporting system database

Wangyu Ye, Zhen Liu|European Journal of Pharmacology|2025

Cited by 2

PMH64 MEASUREMENTS OF ADHERENCE TO ANTI-DEPRESSANT MEDICATIONS

Stephen L. Able, P G Watson, SC Gelwicks et al.|Value in Health|2009

Cited by 0